ImmunoPrecise Antibodies Ltd
NASDAQ:IPA 4:00:00 PM EDT
| Market Cap (Intraday) | 30.42M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.28 |
| 50-Day MA | $1.57 |
| 200-Day MA | $1.76 |
ImmunoPrecise Antibodies Ltd Stock, NASDAQ:IPA
4464 Markham Street, Suite 3204, Victoria, British Columbia V8Z 7X8
Canada
Phone: +1.250.483.0308
Number of Employees: 102
Description
ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.